Atlas Trials

Optimal Dose of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity

Clinical trial NCT02358005 · UNKNOWN

Trial details

NCT number
NCT02358005
Sponsor
Yonsei University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Post-Stroke Elbow Spasticity
Start date
2015-02-01
Primary completion
2019-08-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.